SlideShare a Scribd company logo
DIABETIC KETOACIDOSIS Dr.Padmesh. V Dept of Pediatrics Dr.SMCSI Medical College, Karakonam,  Trivandrum
DKA Diabetic ketoacidosis (DKA) is an acute, major, life-threatening complication of diabetes.  DKA mainly occurs in patients with type 1 diabetes, but it is not uncommon in some patients with type 2 diabetes.  DKA is clinically defined as an acute state of severe uncontrolled diabetes that requires emergency treatment with insulin and intravenous fluids.
DKA :definition A state of  absolute  or  relative   insulin deficiency  resulting in  hyperglycemia  and an accumulation of  ketoacids  in the blood with subsequent  metabolic acidosis Hyperglycemia Blood glucose >250mg% Acidosis pH < 7.30 Bicarb < 20 mmol/L Ketosis Elevated serum or urine ketones Serum ketones >5mEq/L
Physiology of carbohydrate metabolism Glucose and lipid metabolism are regulated by the pancreatic hormone  Insulin ,  and its  C ounter-regulatory hormones : G lucagon G rowth hormone C atecholamines C ortisol
To develop DKA there must be both  a relative  lack of insulin  and  a relative  overactivity of counter-regulatory hormones Insulin   (anabolic) Glucose used for energy substrate or stored as glycogen Protein formation Fats stored as triglycerides C ounterregulatory hormones ( c atabolic) Glycogenolysis Proteolysis-gluconeogenesis Lypolysis-FFA & ketone bodies Physiology
Physiology of DKA Diabetic ketoacidosis is a  superfasted state  in which the body’s tissues are robbed of their normal energy substrate Glucose, And the body resorts to  catabolism of glycogen, protein and fat for energy.
Physiology of carbohydrate metabolism Glycogen is broken down to form glucose ( glycogenolysis ) P rotein is catabolized to  a mino acids which are converted to  g lucose ( gluconeogenesis ) Fats are broken down to free fatty acids, which  are converted in the liver to glucose or ketoacids ( ketogenesis ) To develop DKA there must be both    a relative  lack of insulin  and    a relative  overactivity of counter-regulatory hormones
Thus,this type of hormonal imbalance enhances   Hepatic Gluconeogenesis, Glycogenolysis,  &  Lipolysis.
Hepatic Gluconeogenesis,  Glycogenolysis secondary to insulin deficiency, and counter-regulatory hormone excess  result in severe hyperglycemia. Lipolysis increases  serum free fatty acids .  Hepatic metabolism of free fatty acids as an alternative energy source (ie, ketogenesis) results in  accumulation of acidic metabolites  (ie, ketones, ketoacids).  ( Ketones include acetone, acetoacetate &  beta hydroxybutyrate)
Pathophysiology of DKA Severe insulinopenia or lack of  effective insulin action results in a physiological cascade of events in  3 PATHWAYS
1.  Excessive glucose production +  Reduced glucose utilization Increased serum glucose Osmotic diuresis,with loss of fluids,electrolytes Dehydration Activation of Renin-Angiotensin-Aldosterone axis Accelerated Potassium loss
2.  Increased Catabolic processes Cellular losses of sodium,potassium,phosphate 3.  Increased release of free fatty acids from  peripheral fat stores Substrate for hepatic ketoacid production Ketoacids accumulate Buffer systems are depleted METABOLIC ACIDOSIS occurs
Progressive rise of blood concentration of these acidic organic substances initially leads to a state of  ketonemia.  Natural body buffers can buffer ketonemia in its early stages.  When the accumulated ketones exceed the body's capacity of buffering them, they overflow into urine (ie,  ketonuria ).  If the situation is not treated promptly, more accumulation of organic acids leads to frank clinical metabolic acidosis (ie,  ketoacidosis ), with a drop in pH and bicarbonate serum levels.  Respiratory compensation  of this acidotic condition results in rapid shallow breathing ( Kussmaul respirations ).
Ketones, in particular  beta hydroxybutyrate , induce nausea and vomiting that consequently aggravate fluid and electrolyte loss already existing in DKA. Acetone  produces the characteristic fruity breath odour of ketotic patients. Hyperglycemia usually exceeds the renal threshold of glucose absorption    Significant glycosuria     Osmotic diuresis     Water is lost in urine resulting in Severe dehydration, thirst, tissue hypoperfusion, and, possibly,lactic acidosis.
Hyperglycemia, osmotic diuresis, serum hyperosmolarity, and metabolic acidosis result in severe electrolyte disturbances.  The most characteristic disturbance is total body potassium loss.  This loss is not mirrored in serum potassium levels, which may be low, within the normal range, or even high.
Potassium K +  is largely an intracellular ion. Both lack of insulin (catabolic predominance) and acidosis cause a shift of K +  extracellularly. High urinary losses of K +  occur due to this compartmental shift ,due to osmotic diuresis & due to kaliuretic effect of hyperaldosteronism. Serum K +   levels are usually normal, even when total body K +   is depleted, because: The compartmental shift of K +  inside to outside the cell Only extracellular K +  is measured
Pathophysiology of Potassium loss Acidosis Extracellular accumulation of Hydrogen ions Shift of Potassium from the intracellular to the extracellular space in exchange with hydrogen ions  A large part of this shifted extracellular potassium is lost in urine because of osmotic diuresis HYPOKALEMIA
Sodium Initial serum sodium may be  ‘low’  for several reasons: Depletion secondary to urinary losses / vomiting Hyperlipidemia displaces sodium in the most frequently used laboratory assay, factitiously lowering sodium values. Hyperglycemia     High serum osmolarilty   Water driven from Intra to Extracellular space   Dilutional hyponatremia
For each 100mg% increase of serum glucose above 100mg%, there is an expected decrease of about 1.6mEq/L in measured sodium. The ‘true’ serum sodium level can be calculated as: [Na] + Glucose-100  x 1.6 100 The sodium should  increase  by about 1.6 mmol/L for each 100mg/dL decline in glucose. If the corrected value is >150 mmol/L, severe hypernatremic dehydration may be present and may require slower fluid replacement. Declining sodium may indicate excessive water accumulation & risk of cerebral edema.
With prolonged illness & severe DKA, total body losses can approach: - 10-13 mEq/kg of Sodium -  5-6 mEq/kg of Potassium -  4-5 mEq/kg of Phosphate These losses continue for several hours during therapy until catabolic state is reversed & diuresis is controlled. Even though Sodium deficit may be repaired within  24 hours, intracellular Potassium & Phosphate may not be completely restored for several days.
The combined effects of  Serum hyperosmolarity,  Dehydration, and  Acidosis   Result in increased osmolarity in brain cells  Clinically manifests as an  altered  consciousness.
CLINICAL FEATURES Precipitated by intercurrent illness, trauma, infections. Symptoms: -Nausea / Vomiting -Polydipsia / Polyuria / Nocturia -Abdominal pain -Shortness of breath -Weakness
Signs: - Dehydration - Hypotension - Tachycardia - Tachypnea / Kussmaul respirations  - Acetone odour of breath - Abdominal tenderness  - Lethargy / altered level of  consciousness / possibly coma
Lab Abnormalities and Diagnosis   Serum glucose is elevated  >250mg/dL  Serum bicarbonate  <20 mmol/L Arterial pH  <7.3 , depending on the severity of the acidosis.  Anion gap [ (Na+K)  –  (Cl+HCO3) ]  >12-16 mEq/L Urine analysis: Glucosuria + Ketones
Laboratory Abnormalities and Diagnosis Serum amylase  - may be due to pancreatitis.  (but if S.lipase is not  ,this is likely to be non-specific/salivary) Serum Creatinine may be falsely elevated due to interference by ketones in the autoanalyzer methodology. Blood Urea Nitrogen (BUN) may be elevated. Complete Blood Counts: may reveal possible  infectious etiology. CSF study, CXR to rule out other causes for the clinical condition. Should be re-checked after rehydration
Despite a  total-body potassium deficit , the serum potassium at presentation may be mildly elevated, secondary to the acidosis.  Total-body stores of sodium, chloride, phosphorous, and magnesium are also reduced  in DKA but are not accurately reflected by their levels in the serum because of dehydration and hyperglycemia. Elevated blood urea nitrogen (BUN) and serum creatinine levels  reflect intravascular volume depletion.
To summarize..
In short…
MANAGEMENT  OF   DKA
Aims of management: Restore normal hemodynamic status. Restore normal acid-base balance. Correct blood glucose level. Restore perfusion by giving  fluids , which will increase glucose use in the periphery, restore GFR, and reverse the progressive acidosis. Stop ketogenesis by giving  insulin , which will reverse proteolysis and lipolysis, and stimulate glucose uptake and processing, normalize blood glucose, and reverse acidosis. Correct electrolyte losses by  electrolyte  supplementation. Avoid the complications of treatment, including  intracerebral complications, hypoglycemia, and  hypokalemia.
TREATMENT OF DKA  (Milwaukee DKA PROTOCOL) Time  Therapy  Comments 1 st  hour   10-20 ml/kg IV bolus NS or RL  NPO. Insulin drip at 0.05-0.1 U /kg/ hr  Can be repeated. 2 nd  hour until  0.45% NS  +  Continue insulin drip .  If K<3mEq/L, give 0.5-1mEq/Kg DKA resolution  20 mEq/L Kphos & 20 mEq/L KAc.  as oral K soln or increase IV K 5% glucose if bl.sugar <250mg/dL  to 80 mEq/L Variable  Oral intake + S/C insulin  No emesis.Normal electrolytes. CO2 >16mEq/L. pH>7.30 IV rate =  85ml/kg  + maintenance – bolus 23 hr * *
This protocol  corrects a deficit of 85ml/kg (8.5% dehydration)  for all patients in the first 24 hours. Children with mild DKA rehydrate earlier & can be switched to oral intake, whereas those with severe DKA and a greater volume deficit require 30-36 hours with this protocol. The initial BOLUS given is a sugar free   ISOTONIC  solution. The patient is invariably hypertonic,keeping most of the initial infusion in the  intravascular space . This ensures quick volume expansion. Subsequent fluid is  HYPOTONIC   t o repair the free water deficit,to allow  intracellular   rehydration and to allow a more appropriate replacement of on-going hypotonic urine losses. IV rate =  85ml/kg  + maintenance – bolus 23 hr
Insulin should be given at the beginning to -accelerate the movement of glucose into cells -to subdue hepatic glucose production -to halt movement of fatty acids from periphery to liver However,an initial insulin BOLUS does NOT speed recovery,and may increase the risk of hypoglycemia and hypokalemia. Therefore,insulin  INFUSION  is started (WITHOUT A BOLUS) at the  rate of 0.1 U/kg/hour. Rehydration also lowers glucose levels by -improving renal perfusion     enhancing renal excretion Once glucose level goes below 180 mg/dL, osmotic diuresis stops and therefore rehydration becomes faster without further increase in fluid infusion rate.
Hyperglycemia is corrected well before the correction of acidosis.  Therefore,even after normal glucose levels are reached, insulin is  still required to control fatty acid release. Thus insulin infusion can be lowered but NOT STOPPED once  hyperglycemia has resolved. However ,to continue insulin infusion without causing  hypoglycemia, GLUCOSE should be added to the solution-  usually as a 5% solution. This glucose is added when serum glucose has decreased to 250  mg/dL, so that there is sufficient time to infusion before serum  glucose falls further.
Cautious rehydration : Important to approach any child with hyperosmotic state with cautious rehydration. Effective Serum Osmolality = {  2  x  [Na uncorrected] + [Glucose]  } (This is an accurate index of tonicity of body fluids reflecting the intracellular & extracellular hydration better than measured plasma osmolality.) This value is usually elevated in the beginning,and should gradually normalize. A rapid decline or a slow decline to a sub-normal range may indicate an excess of free water entering the vascular space,and therefore an increasing risk of developing  CEREBRAL EDEMA.
Complications of DKA Dehydration/shock/ hypotension  Hypokalemia – hyperkalemia Hypoglycemia  Aspiration pneumonia Sepsis Acute tubular necrosis Myocardial infarction Stroke Cerebral edema
Cerebral edema Clinically apparent cerebral edema occurs in approximately 1% of childhood DKA and is associated with high mortality and neurological morbidity. The pathogenesis of the cerebral edema is not understood; Some studies have attributed it to cellular swelling as a result of rapid osmolar changes occurring during intravenous infusions. Several studies, however, have shown no relationship to the volume or sodium content of the infusion nor any association with the rate of change in serum glucose concentration. This suggests that other factors may be important in the pathophysiology of DKA-related cerebral edema. Clinical signs are variable Gradual deterioration and worsening of conscious level, or  More commonly a gradual general improvement followed by sudden neurological deterioration Requires a high index of suspicion.
Cerebral Edema – Clinical Features: Decreased sensorium Sudden and severe headache Incontinence Persistent vomiting Disorientation; agitation Ophthalmoplegia Pupillary changes Papilledema Posturing; Seizure
Cerebral edema –Treatment : Urgent recognition and treatment are essential. Mannitol Reduce IV fluid rate to 70% maintenance  Elevate head end of bed to 45 o Consider intubation & Controlled hyperventilation  ( vasoconstrictor effect of hypocarbia)
PREVENTION  IS  BETTER THAN CURE!!!
 

More Related Content

PPT
DKA in children
PPTX
Diabetic Ketoacidosis in Children (DKA)
PPTX
Dibetic Ketoacidosis in Children
PDF
Dka management in children
PPT
Pediatrics DKA slide set updated
PPTX
Diabetic ketoacidosis in children
PPT
DKA diabetes ketoacidosis in children.ppt
PDF
Diabetes+ketoacidosis
DKA in children
Diabetic Ketoacidosis in Children (DKA)
Dibetic Ketoacidosis in Children
Dka management in children
Pediatrics DKA slide set updated
Diabetic ketoacidosis in children
DKA diabetes ketoacidosis in children.ppt
Diabetes+ketoacidosis

What's hot (20)

PPTX
Pancreatitis in pediatrics
PPTX
Bronchiolitis
PPTX
persistent diarrhea & Chronic diarrhea
PPTX
Pediatric Acute Liver Failure
PDF
Syndrome of Inappropriate Anti-diuretic Hormone Secretion (SIADH)
PPTX
Hemolytic uremic syndrome
PPTX
Approach to Hypoglycemia in childhood
PPTX
Pediatric hypertension
PPTX
URINARY TRACT INFECTION IN CHILDREN
PPTX
Acute kidney injury in pediatrics
PPTX
An approach to a Floppy infant - Dr Sujit
PPTX
Constipation in children
PDF
Febrile seizures
PPT
Approach to a child with Hepatosplenomegaly
PPTX
Nocturnal Enuresis
PPTX
Respiratory distress in newborn
PPTX
Heart failure in children
PPTX
Pediatric stroke
PPTX
Pneumonia in children
PPTX
Meningitis (Pediatrics Lecture)
Pancreatitis in pediatrics
Bronchiolitis
persistent diarrhea & Chronic diarrhea
Pediatric Acute Liver Failure
Syndrome of Inappropriate Anti-diuretic Hormone Secretion (SIADH)
Hemolytic uremic syndrome
Approach to Hypoglycemia in childhood
Pediatric hypertension
URINARY TRACT INFECTION IN CHILDREN
Acute kidney injury in pediatrics
An approach to a Floppy infant - Dr Sujit
Constipation in children
Febrile seizures
Approach to a child with Hepatosplenomegaly
Nocturnal Enuresis
Respiratory distress in newborn
Heart failure in children
Pediatric stroke
Pneumonia in children
Meningitis (Pediatrics Lecture)
Ad

Viewers also liked (9)

PPT
Diabetic Ketoacidosis In Children
PPT
Diabetic Ketoacidosis
PPTX
Massive transfusion
PPT
Massive Transfusion in Trauma
PPT
Dka diabetic ketoacidosis managment
PPTX
Diabetic Ketoacidosis. A Review
PPTX
Diabetic Ketoacidosis
PPTX
DIABETIC KETOACIDOSIS PRESENTATION BY ROOMA KHALID
PPT
Blood transfusion
Diabetic Ketoacidosis In Children
Diabetic Ketoacidosis
Massive transfusion
Massive Transfusion in Trauma
Dka diabetic ketoacidosis managment
Diabetic Ketoacidosis. A Review
Diabetic Ketoacidosis
DIABETIC KETOACIDOSIS PRESENTATION BY ROOMA KHALID
Blood transfusion
Ad

Similar to Diabetic keto acidosis in children ... Dr.Padmesh (20)

PPTX
Diabetic Ketoacidosis.pptx
PPTX
Diabetic Ketoacidosis Preye & Godwin-WPS Office.pptx
PPT
Diabetic ketoacidosis dka- egh-nsg.forum-palestine.com
PPTX
Diabetic ketoacidosis (DKA) MedicalBooksVN.wordpress.com/
PDF
DIABETIC KETOACIDOSIS final. Present by Dr Nasir Uddin
PPTX
Diabetic Ketoacidosis
PPTX
NCM 116- diabetic ketoacidosis.pptx
PPTX
Diabetic ketoacidosis
PPTX
PPTX
ACUTE COMPLICATIONS OF DIABETES MELLITUS (DCM-320) (1).pptx
PPTX
Acute complications of Diabetes Mellitus
PPTX
Diabetic KetoAcidosis / DKA
PPTX
PPT
DIABETIC KETOACIDOSIS IN ER
PPTX
PPT
43651 (1).ppt diabetic keto acidosis in ediatrics
PPTX
Diabetic keto acidosis ppt
PPT
Diabetic ketoacidosis lecture 1
PPT
2 DIABETES KETOACIDOSIS (DKA) presentation
PPT
Diabetic ketoacidosis
Diabetic Ketoacidosis.pptx
Diabetic Ketoacidosis Preye & Godwin-WPS Office.pptx
Diabetic ketoacidosis dka- egh-nsg.forum-palestine.com
Diabetic ketoacidosis (DKA) MedicalBooksVN.wordpress.com/
DIABETIC KETOACIDOSIS final. Present by Dr Nasir Uddin
Diabetic Ketoacidosis
NCM 116- diabetic ketoacidosis.pptx
Diabetic ketoacidosis
ACUTE COMPLICATIONS OF DIABETES MELLITUS (DCM-320) (1).pptx
Acute complications of Diabetes Mellitus
Diabetic KetoAcidosis / DKA
DIABETIC KETOACIDOSIS IN ER
43651 (1).ppt diabetic keto acidosis in ediatrics
Diabetic keto acidosis ppt
Diabetic ketoacidosis lecture 1
2 DIABETES KETOACIDOSIS (DKA) presentation
Diabetic ketoacidosis

More from Dr Padmesh Vadakepat (20)

PPTX
Neonatal Nursing of Extremely Premature Neonates - Dr Padmesh
PPTX
Update on Antenatal Steroids 2021 - Dr Padmesh
PPTX
Inhaled Nitric Oxide (iNO) in Newborns - Dr Padmesh - Neonatology
PPTX
Approach to Ano Rectal Malformations - Dr Padmesh - Neonatology
PPTX
ROP - Dr Padmesh - Neonatology
PPTX
Blood Group Selection in Newborn Transfusion - Dr Padmesh - Neonatology
PPTX
Vaccination in Preterms by - Dr Padmesh - Neonatology
PPTX
European Consensus Statement on RDS 2019
PPTX
Blood Brain Barrier by Dr Padmesh V
PPTX
Humidication in NICU - Dr Padmesh - Neonatology
PPTX
Subgaleal Hemorrhage - Dr Padmesh - Neonatology
PPTX
Touch and Massage Therapy in Newborn - Dr Padmesh V
PPTX
Perinatal infections- Diagnosis & Management - Dr Padmesh - Neonatology
PPTX
Shock & Inotropes in Neonates - Dr Padmesh - Neonatology
PPTX
ABC of ABG - Dr Padmesh
PPTX
Assessment of Fetal Well being - Dr Padmesh - Neonatology
PPTX
Ballard score.. - Dr Padmesh - Neonatology
PPTX
European Consensus Guidelines- RDS in Preterm Newborns
PPTX
Say NO to drugs .. Dr.Padmesh
PPTX
Pulmonary Abscess in Children .. Dr Padmesh
Neonatal Nursing of Extremely Premature Neonates - Dr Padmesh
Update on Antenatal Steroids 2021 - Dr Padmesh
Inhaled Nitric Oxide (iNO) in Newborns - Dr Padmesh - Neonatology
Approach to Ano Rectal Malformations - Dr Padmesh - Neonatology
ROP - Dr Padmesh - Neonatology
Blood Group Selection in Newborn Transfusion - Dr Padmesh - Neonatology
Vaccination in Preterms by - Dr Padmesh - Neonatology
European Consensus Statement on RDS 2019
Blood Brain Barrier by Dr Padmesh V
Humidication in NICU - Dr Padmesh - Neonatology
Subgaleal Hemorrhage - Dr Padmesh - Neonatology
Touch and Massage Therapy in Newborn - Dr Padmesh V
Perinatal infections- Diagnosis & Management - Dr Padmesh - Neonatology
Shock & Inotropes in Neonates - Dr Padmesh - Neonatology
ABC of ABG - Dr Padmesh
Assessment of Fetal Well being - Dr Padmesh - Neonatology
Ballard score.. - Dr Padmesh - Neonatology
European Consensus Guidelines- RDS in Preterm Newborns
Say NO to drugs .. Dr.Padmesh
Pulmonary Abscess in Children .. Dr Padmesh

Recently uploaded (20)

PPTX
Electromyography (EMG) in Physiotherapy: Principles, Procedure & Clinical App...
PDF
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
PPTX
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
PPTX
Pathophysiology And Clinical Features Of Peripheral Nervous System .pptx
PDF
coagulation disorders in anaesthesia pdf
PDF
Rheumatoid arthritis RA_and_the_liver Prof AbdelAzeim Elhefny Ain Shams Univ...
PPTX
Note on Abortion.pptx for the student note
PPTX
ACID BASE management, base deficit correction
PPTX
neonatal infection(7392992y282939y5.pptx
PPTX
anal canal anatomy with illustrations...
PPTX
CEREBROVASCULAR DISORDER.POWERPOINT PRESENTATIONx
PPTX
NEET PG 2025: Memory-Based Recall Questions Compiled by Dr. Shivankan Kakkar, MD
PPTX
NEET PG 2025 Pharmacology Recall | Real Exam Questions from 3rd August with D...
PPT
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
PPTX
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA.pptx
DOCX
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
PPT
Management of Acute Kidney Injury at LAUTECH
PPTX
SKIN Anatomy and physiology and associated diseases
PPTX
Fundamentals of human energy transfer .pptx
PPTX
History and examination of abdomen, & pelvis .pptx
Electromyography (EMG) in Physiotherapy: Principles, Procedure & Clinical App...
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
Pathophysiology And Clinical Features Of Peripheral Nervous System .pptx
coagulation disorders in anaesthesia pdf
Rheumatoid arthritis RA_and_the_liver Prof AbdelAzeim Elhefny Ain Shams Univ...
Note on Abortion.pptx for the student note
ACID BASE management, base deficit correction
neonatal infection(7392992y282939y5.pptx
anal canal anatomy with illustrations...
CEREBROVASCULAR DISORDER.POWERPOINT PRESENTATIONx
NEET PG 2025: Memory-Based Recall Questions Compiled by Dr. Shivankan Kakkar, MD
NEET PG 2025 Pharmacology Recall | Real Exam Questions from 3rd August with D...
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA.pptx
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
Management of Acute Kidney Injury at LAUTECH
SKIN Anatomy and physiology and associated diseases
Fundamentals of human energy transfer .pptx
History and examination of abdomen, & pelvis .pptx

Diabetic keto acidosis in children ... Dr.Padmesh

  • 1. DIABETIC KETOACIDOSIS Dr.Padmesh. V Dept of Pediatrics Dr.SMCSI Medical College, Karakonam, Trivandrum
  • 2. DKA Diabetic ketoacidosis (DKA) is an acute, major, life-threatening complication of diabetes. DKA mainly occurs in patients with type 1 diabetes, but it is not uncommon in some patients with type 2 diabetes. DKA is clinically defined as an acute state of severe uncontrolled diabetes that requires emergency treatment with insulin and intravenous fluids.
  • 3. DKA :definition A state of absolute or relative insulin deficiency resulting in hyperglycemia and an accumulation of ketoacids in the blood with subsequent metabolic acidosis Hyperglycemia Blood glucose >250mg% Acidosis pH < 7.30 Bicarb < 20 mmol/L Ketosis Elevated serum or urine ketones Serum ketones >5mEq/L
  • 4. Physiology of carbohydrate metabolism Glucose and lipid metabolism are regulated by the pancreatic hormone Insulin , and its C ounter-regulatory hormones : G lucagon G rowth hormone C atecholamines C ortisol
  • 5. To develop DKA there must be both a relative lack of insulin and a relative overactivity of counter-regulatory hormones Insulin (anabolic) Glucose used for energy substrate or stored as glycogen Protein formation Fats stored as triglycerides C ounterregulatory hormones ( c atabolic) Glycogenolysis Proteolysis-gluconeogenesis Lypolysis-FFA & ketone bodies Physiology
  • 6. Physiology of DKA Diabetic ketoacidosis is a superfasted state in which the body’s tissues are robbed of their normal energy substrate Glucose, And the body resorts to catabolism of glycogen, protein and fat for energy.
  • 7. Physiology of carbohydrate metabolism Glycogen is broken down to form glucose ( glycogenolysis ) P rotein is catabolized to a mino acids which are converted to g lucose ( gluconeogenesis ) Fats are broken down to free fatty acids, which are converted in the liver to glucose or ketoacids ( ketogenesis ) To develop DKA there must be both a relative lack of insulin and a relative overactivity of counter-regulatory hormones
  • 8. Thus,this type of hormonal imbalance enhances Hepatic Gluconeogenesis, Glycogenolysis, & Lipolysis.
  • 9. Hepatic Gluconeogenesis, Glycogenolysis secondary to insulin deficiency, and counter-regulatory hormone excess result in severe hyperglycemia. Lipolysis increases serum free fatty acids . Hepatic metabolism of free fatty acids as an alternative energy source (ie, ketogenesis) results in accumulation of acidic metabolites (ie, ketones, ketoacids). ( Ketones include acetone, acetoacetate & beta hydroxybutyrate)
  • 10. Pathophysiology of DKA Severe insulinopenia or lack of effective insulin action results in a physiological cascade of events in 3 PATHWAYS
  • 11. 1. Excessive glucose production + Reduced glucose utilization Increased serum glucose Osmotic diuresis,with loss of fluids,electrolytes Dehydration Activation of Renin-Angiotensin-Aldosterone axis Accelerated Potassium loss
  • 12. 2. Increased Catabolic processes Cellular losses of sodium,potassium,phosphate 3. Increased release of free fatty acids from peripheral fat stores Substrate for hepatic ketoacid production Ketoacids accumulate Buffer systems are depleted METABOLIC ACIDOSIS occurs
  • 13. Progressive rise of blood concentration of these acidic organic substances initially leads to a state of ketonemia. Natural body buffers can buffer ketonemia in its early stages. When the accumulated ketones exceed the body's capacity of buffering them, they overflow into urine (ie, ketonuria ). If the situation is not treated promptly, more accumulation of organic acids leads to frank clinical metabolic acidosis (ie, ketoacidosis ), with a drop in pH and bicarbonate serum levels. Respiratory compensation of this acidotic condition results in rapid shallow breathing ( Kussmaul respirations ).
  • 14. Ketones, in particular beta hydroxybutyrate , induce nausea and vomiting that consequently aggravate fluid and electrolyte loss already existing in DKA. Acetone produces the characteristic fruity breath odour of ketotic patients. Hyperglycemia usually exceeds the renal threshold of glucose absorption  Significant glycosuria  Osmotic diuresis  Water is lost in urine resulting in Severe dehydration, thirst, tissue hypoperfusion, and, possibly,lactic acidosis.
  • 15. Hyperglycemia, osmotic diuresis, serum hyperosmolarity, and metabolic acidosis result in severe electrolyte disturbances. The most characteristic disturbance is total body potassium loss. This loss is not mirrored in serum potassium levels, which may be low, within the normal range, or even high.
  • 16. Potassium K + is largely an intracellular ion. Both lack of insulin (catabolic predominance) and acidosis cause a shift of K + extracellularly. High urinary losses of K + occur due to this compartmental shift ,due to osmotic diuresis & due to kaliuretic effect of hyperaldosteronism. Serum K + levels are usually normal, even when total body K + is depleted, because: The compartmental shift of K + inside to outside the cell Only extracellular K + is measured
  • 17. Pathophysiology of Potassium loss Acidosis Extracellular accumulation of Hydrogen ions Shift of Potassium from the intracellular to the extracellular space in exchange with hydrogen ions A large part of this shifted extracellular potassium is lost in urine because of osmotic diuresis HYPOKALEMIA
  • 18. Sodium Initial serum sodium may be ‘low’ for several reasons: Depletion secondary to urinary losses / vomiting Hyperlipidemia displaces sodium in the most frequently used laboratory assay, factitiously lowering sodium values. Hyperglycemia  High serum osmolarilty  Water driven from Intra to Extracellular space  Dilutional hyponatremia
  • 19. For each 100mg% increase of serum glucose above 100mg%, there is an expected decrease of about 1.6mEq/L in measured sodium. The ‘true’ serum sodium level can be calculated as: [Na] + Glucose-100 x 1.6 100 The sodium should increase by about 1.6 mmol/L for each 100mg/dL decline in glucose. If the corrected value is >150 mmol/L, severe hypernatremic dehydration may be present and may require slower fluid replacement. Declining sodium may indicate excessive water accumulation & risk of cerebral edema.
  • 20. With prolonged illness & severe DKA, total body losses can approach: - 10-13 mEq/kg of Sodium - 5-6 mEq/kg of Potassium - 4-5 mEq/kg of Phosphate These losses continue for several hours during therapy until catabolic state is reversed & diuresis is controlled. Even though Sodium deficit may be repaired within 24 hours, intracellular Potassium & Phosphate may not be completely restored for several days.
  • 21. The combined effects of Serum hyperosmolarity, Dehydration, and Acidosis Result in increased osmolarity in brain cells Clinically manifests as an altered consciousness.
  • 22. CLINICAL FEATURES Precipitated by intercurrent illness, trauma, infections. Symptoms: -Nausea / Vomiting -Polydipsia / Polyuria / Nocturia -Abdominal pain -Shortness of breath -Weakness
  • 23. Signs: - Dehydration - Hypotension - Tachycardia - Tachypnea / Kussmaul respirations - Acetone odour of breath - Abdominal tenderness - Lethargy / altered level of consciousness / possibly coma
  • 24. Lab Abnormalities and Diagnosis Serum glucose is elevated >250mg/dL Serum bicarbonate <20 mmol/L Arterial pH <7.3 , depending on the severity of the acidosis. Anion gap [ (Na+K) – (Cl+HCO3) ] >12-16 mEq/L Urine analysis: Glucosuria + Ketones
  • 25. Laboratory Abnormalities and Diagnosis Serum amylase - may be due to pancreatitis. (but if S.lipase is not ,this is likely to be non-specific/salivary) Serum Creatinine may be falsely elevated due to interference by ketones in the autoanalyzer methodology. Blood Urea Nitrogen (BUN) may be elevated. Complete Blood Counts: may reveal possible infectious etiology. CSF study, CXR to rule out other causes for the clinical condition. Should be re-checked after rehydration
  • 26. Despite a total-body potassium deficit , the serum potassium at presentation may be mildly elevated, secondary to the acidosis. Total-body stores of sodium, chloride, phosphorous, and magnesium are also reduced in DKA but are not accurately reflected by their levels in the serum because of dehydration and hyperglycemia. Elevated blood urea nitrogen (BUN) and serum creatinine levels reflect intravascular volume depletion.
  • 30. Aims of management: Restore normal hemodynamic status. Restore normal acid-base balance. Correct blood glucose level. Restore perfusion by giving fluids , which will increase glucose use in the periphery, restore GFR, and reverse the progressive acidosis. Stop ketogenesis by giving insulin , which will reverse proteolysis and lipolysis, and stimulate glucose uptake and processing, normalize blood glucose, and reverse acidosis. Correct electrolyte losses by electrolyte supplementation. Avoid the complications of treatment, including intracerebral complications, hypoglycemia, and hypokalemia.
  • 31. TREATMENT OF DKA (Milwaukee DKA PROTOCOL) Time Therapy Comments 1 st hour 10-20 ml/kg IV bolus NS or RL NPO. Insulin drip at 0.05-0.1 U /kg/ hr Can be repeated. 2 nd hour until 0.45% NS + Continue insulin drip . If K<3mEq/L, give 0.5-1mEq/Kg DKA resolution 20 mEq/L Kphos & 20 mEq/L KAc. as oral K soln or increase IV K 5% glucose if bl.sugar <250mg/dL to 80 mEq/L Variable Oral intake + S/C insulin No emesis.Normal electrolytes. CO2 >16mEq/L. pH>7.30 IV rate = 85ml/kg + maintenance – bolus 23 hr * *
  • 32. This protocol corrects a deficit of 85ml/kg (8.5% dehydration) for all patients in the first 24 hours. Children with mild DKA rehydrate earlier & can be switched to oral intake, whereas those with severe DKA and a greater volume deficit require 30-36 hours with this protocol. The initial BOLUS given is a sugar free ISOTONIC solution. The patient is invariably hypertonic,keeping most of the initial infusion in the intravascular space . This ensures quick volume expansion. Subsequent fluid is HYPOTONIC t o repair the free water deficit,to allow intracellular rehydration and to allow a more appropriate replacement of on-going hypotonic urine losses. IV rate = 85ml/kg + maintenance – bolus 23 hr
  • 33. Insulin should be given at the beginning to -accelerate the movement of glucose into cells -to subdue hepatic glucose production -to halt movement of fatty acids from periphery to liver However,an initial insulin BOLUS does NOT speed recovery,and may increase the risk of hypoglycemia and hypokalemia. Therefore,insulin INFUSION is started (WITHOUT A BOLUS) at the rate of 0.1 U/kg/hour. Rehydration also lowers glucose levels by -improving renal perfusion  enhancing renal excretion Once glucose level goes below 180 mg/dL, osmotic diuresis stops and therefore rehydration becomes faster without further increase in fluid infusion rate.
  • 34. Hyperglycemia is corrected well before the correction of acidosis. Therefore,even after normal glucose levels are reached, insulin is still required to control fatty acid release. Thus insulin infusion can be lowered but NOT STOPPED once hyperglycemia has resolved. However ,to continue insulin infusion without causing hypoglycemia, GLUCOSE should be added to the solution- usually as a 5% solution. This glucose is added when serum glucose has decreased to 250 mg/dL, so that there is sufficient time to infusion before serum glucose falls further.
  • 35. Cautious rehydration : Important to approach any child with hyperosmotic state with cautious rehydration. Effective Serum Osmolality = { 2 x [Na uncorrected] + [Glucose] } (This is an accurate index of tonicity of body fluids reflecting the intracellular & extracellular hydration better than measured plasma osmolality.) This value is usually elevated in the beginning,and should gradually normalize. A rapid decline or a slow decline to a sub-normal range may indicate an excess of free water entering the vascular space,and therefore an increasing risk of developing CEREBRAL EDEMA.
  • 36. Complications of DKA Dehydration/shock/ hypotension Hypokalemia – hyperkalemia Hypoglycemia Aspiration pneumonia Sepsis Acute tubular necrosis Myocardial infarction Stroke Cerebral edema
  • 37. Cerebral edema Clinically apparent cerebral edema occurs in approximately 1% of childhood DKA and is associated with high mortality and neurological morbidity. The pathogenesis of the cerebral edema is not understood; Some studies have attributed it to cellular swelling as a result of rapid osmolar changes occurring during intravenous infusions. Several studies, however, have shown no relationship to the volume or sodium content of the infusion nor any association with the rate of change in serum glucose concentration. This suggests that other factors may be important in the pathophysiology of DKA-related cerebral edema. Clinical signs are variable Gradual deterioration and worsening of conscious level, or More commonly a gradual general improvement followed by sudden neurological deterioration Requires a high index of suspicion.
  • 38. Cerebral Edema – Clinical Features: Decreased sensorium Sudden and severe headache Incontinence Persistent vomiting Disorientation; agitation Ophthalmoplegia Pupillary changes Papilledema Posturing; Seizure
  • 39. Cerebral edema –Treatment : Urgent recognition and treatment are essential. Mannitol Reduce IV fluid rate to 70% maintenance Elevate head end of bed to 45 o Consider intubation & Controlled hyperventilation ( vasoconstrictor effect of hypocarbia)
  • 40. PREVENTION IS BETTER THAN CURE!!!
  • 41.